NED
VRTX icon

Nancy E. Dempze’s Vertex Pharmaceuticals VRTX Stock Holding History

Nancy E. Dempze’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.11M Buy
8,282
+472
+6% +$209K 1.97% 18
2026
Q1 		$3.49M Buy
7,810
+752
+11% +$351K 1.92% 21
2025
Q4 		$3.2M Sell
7,058
-194
-3% -$83.6K 1.67% 22
2025
Q3 		$2.84M Buy
7,252
+72
+1% +$30.1K 1.56% 25
2025
Q2 		$3.2M Buy
7,180
+117
+2% +$53.9K 1.84% 23
2025
Q1 		$3.42M Buy
7,063
+986
+16% +$459K 2.06% 21
2024
Q4 		$2.45M Buy
6,077
+1,208
+25% +$560K 1.41% 27
2024
Q3 		$2.26M Buy
4,869
+2,286
+89% +$1.1M 1.26% 29
2024
Q2 		$1.21M Buy
2,583
+1,878
+266% +$815K 0.83% 35
2024
Q1 		$295K Buy
+705
New +$298K 0.22% 52

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Nancy E. Dempze's VRTX Position: Q2 2026 in Review

Nancy E. Dempze increased its Vertex Pharmaceuticals (VRTX) stake by 6% in Q2 2026, buying an estimated $209K and bringing the position to 8,282 shares worth $4.11M. The position accounts for 1.97% of the portfolio, ranked #18.

Nancy E. Dempze first reported a position in VRTX in Q1 2024 and has held it in 10 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Nancy E. Dempze held 8,282 shares of Vertex Pharmaceuticals worth $4.11M as of Q2 2026.
  • Nancy E. Dempze bought 472 Vertex Pharmaceuticals shares in Q2 2026, an estimated $209K.
  • Vertex Pharmaceuticals made up 1.97% of Nancy E. Dempze's portfolio in Q2 2026, its #18 holding.
  • Nancy E. Dempze first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Nancy E. Dempze's 13F filing for Q2 2026, filed 13 Aug 2026.